Charles River Laboratories (CRL)

Currency in USD
156.68
+0.88(+0.56%)
Closed·
156.680.00(0.00%)
·

CRL Financial Summary

Key Ratios

P/E Ratio-108.96
Price/Book2.2
Debt / Equity82.04%
Return on Equity-1.81%
Dividend Yield0.00%
EBITDA898.20M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
26/12
2016
31/12
2017
30/12
2018
29/12
2019
28/12
2020
26/12
2021
25/12
2022
31/12
2023
30/12
2024
28/12
* In Millions of USD (except for per share items)

Analyst Ratings

5 Buy
12 Hold
1 Sell
Ratings:
18 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 168.75
(+7.70% Upside)

Earnings

Latest Release
Aug 06, 2025
EPS / Forecast
3.12 / 2.50
Revenue / Forecast
1.03B / 984.86M
EPS Revisions
Last 90 days

FAQ

What were Charles River Laboratories's earnings for the latest quarter?

The Charles River Laboratories EPS (TTM) is -1.37. Charles River Laboratories reported sales of 1,032.14, net income of 52.33, and EPS of 3.12 for the latest quarter.

What was Charles River Laboratories's net income for the latest quarter?

Charles River Laboratories's net income for the latest quarter was 52.33.

How did Charles River Laboratories's performance compare year-over-year in the latest quarter?

The company's revenue moved from 984.17 in the previous quarter to 1,032.14 in the latest quarter, and net income moved from 25.47 to 52.33 compared to the previous quarter.

What is Charles River Laboratories's net profit margin on a TTM basis?

Charles River Laboratories's trailing twelve months (TTM) net profit margin is 0.55%.

How does Charles River Laboratories's debt to equity ratio compare to industry standards?

Charles River Laboratories's total debt-to-equity ratio is 82.04%.

What is Charles River Laboratories's return on investment on a TTM basis?

Charles River Laboratories's trailing twelve months (TTM) return on investment (ROI) is -1.81%.

Did Charles River Laboratories gain or lose cash last quarter?

In the latest quarter, Charles River Laboratories's net change in cash was -46.99 million.

What were Charles River Laboratories's total assets and liabilities in the latest quarter?

As of the latest quarter, Charles River Laboratories reported total assets of 7,560.55 million and total liabilities of 1,080.44 million.

How has Charles River Laboratories's total revenue grown this year?

Charles River Laboratories's total revenue was 984.17 in the previous quarter and 1,032.14 in the latest quarter.

What is Charles River Laboratories's gross margin on a TTM basis?

Charles River Laboratories's trailing twelve months (TTM) gross margin is 35.03%.

What was Charles River Laboratories's revenue per share for the latest quarter?

Charles River Laboratories's revenue per share for the latest quarter was 3.09.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.